OtherGastrointestinal, Hepatic, Pulmonary, and Renal
A novel, long-acting agonist of glucose dependent insulinotropic polypeptide (GIP) suitable for once daily administration in type 2 diabetes
Nigel Irwin, Brian D Green, Mark H Mooney, Brett Greer, Patrick Harriott, Clifford J Bailey, Victor A Gault, Finbarr PM O'Harte and Peter R Flatt
Journal of Pharmacology and Experimental Therapeutics May 27, 2005, DOI: https://doi.org/10.1124/jpet.105.086082